Regentatlantic Capital LLC Thermo Fisher Scientific Inc. Transaction History

Regentatlantic Capital LLC

$3.34 Billion
Q3 2022

A detailed history of Regentatlantic Capital LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Regentatlantic Capital LLC holds 41,755 shares of TMO stock, worth $21.9 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares

41,755

Previous 42,213 1.08%

Holding current value

$21.9 Million

Previous $22.9 Million 7.66%

% of portfolio

0.63%

Previous 0.76%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$507.19 - $604.49 $232,293 - $276,856	-458 Reduced 1.08%	41,755 $21.2 Million
Q2 2022 Aug 15, 2022	SELL	$500.9 - $612.21 $243,437 - $297,534	-486 Reduced 1.14%	42,213 $22.9 Million
Q1 2022 May 02, 2022	SELL	$524.0 - $644.92 $293,964 - $361,800	-561 Reduced 1.3%	42,699 $25.2 Million
Q4 2021 Jan 27, 2022	BUY	$569.0 - $667.24 $35,847 - $42,036	63 Added 0.15%	43,260 $28.9 Million
Q3 2021 Nov 15, 2021	SELL	$509.53 - $609.78 $219,607 - $262,815	-431 Reduced 0.99%	43,197 $24.7 Million
Q2 2021 Aug 12, 2021	SELL	$441.0 - $508.24 $226,674 - $261,235	-514 Reduced 1.16%	43,628 $22 Million
Q1 2021 Apr 29, 2021	BUY	$439.85 - $518.83 $382,669 - $451,382	870 Added 2.01%	44,142 $20.1 Million
Q4 2020 Feb 04, 2021	SELL	$435.06 - $527.66 $253,204 - $307,098	-582 Reduced 1.33%	43,272 $20.2 Million
Q3 2020 Oct 13, 2020	BUY	$359.77 - $441.52 $670,251 - $822,551	1,863 Added 4.44%	43,854 $19.4 Million
Q2 2020 Aug 13, 2020	SELL	$275.2 - $362.34 $385,830 - $508,000	-1,402 Reduced 3.23%	41,991 $15.2 Million
Q1 2020 May 14, 2020	SELL	$255.3 - $340.05 $833,299 - $1.11 Million	-3,264 Reduced 7.0%	43,393 $12.3 Million
Q4 2019 Feb 04, 2020	SELL	$271.93 - $328.04 $501,166 - $604,577	-1,843 Reduced 3.8%	46,657 $15.2 Million
Q3 2019 Oct 22, 2019	SELL	$268.46 - $305.43 $460,945 - $524,423	-1,717 Reduced 3.42%	48,500 $14.1 Million
Q2 2019 Jul 23, 2019	SELL	$257.51 - $295.55 $305,406 - $350,522	-1,186 Reduced 2.31%	50,217 $14.7 Million
Q1 2019 May 03, 2019	SELL	$212.17 - $273.72 $609,140 - $785,850	-2,871 Reduced 5.29%	51,403 $14.1 Million
Q4 2018 Jan 30, 2019	SELL	$208.47 - $251.98 $244,118 - $295,068	-1,171 Reduced 2.11%	54,274 $12.1 Million
Q3 2018 Oct 30, 2018	SELL	$205.57 - $244.32 $222,426 - $264,354	-1,082 Reduced 1.91%	55,445 $13.5 Million
Q2 2018 Jul 31, 2018	SELL	$203.14 - $219.53 $154,589 - $167,062	-761 Reduced 1.33%	56,527 $11.7 Million
Q1 2018 Apr 23, 2018	SELL	$192.98 - $224.11 $219,997 - $255,485	-1,140 Reduced 1.95%	57,288 $11.8 Million
Q4 2017 Jan 23, 2018	SELL	$182.03 - $200.37 $372,797 - $410,357	-2,048 Reduced 3.39%	58,428 $11.1 Million
Q3 2017 Oct 25, 2017	BUY	$171.74 - $194.04 $10.4 Million - $11.7 Million	60,476	60,476 $11.4 Million

Others Institutions Holding TMO

# of Institutions

2,835

Shares Held

333M

Call Options Held

2.37M

Put Options Held

2.75M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $205B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.

Account

Regentatlantic Capital LLC Thermo Fisher Scientific Inc. Transaction History